Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Revue Neurologique|January 15, 2002
[Therapeutic indications for managing symptoms: fatigue]E WaubantPathologie-Biologie|May 18, 2000
Methodological problems in evaluating efficacy of a treatment in multiple sclerosisE Waubant, D GoodkinMultiple Sclerosis and Related Disorders|February 8, 2018
Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawalJ Chong, M Cohen, E WaubantEuropean Journal of Neurology|July 15, 2016
Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal studyB Nourbakhsh, L Julian, E WaubantMultiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2012
Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherenceG Giovannoni, E Southam, E WaubantJournal of Neurology, Neurosurgery, and Psychiatry|January 29, 2008
Predictors of the location of multiple sclerosis relapseS Deen, P Bacchetti, A High, et al.Revue Neurologique|June 15, 1999
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]E Waubant, R Sloan, P B Andersson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2014
Composite end points to assess delay of disability progression by MS treatmentsJ Zhang, E Waubant, G Cutter, et al.Pageof 6